Berens covers the Healthcare sector, focusing on stocks such as AVEO Pharma, Seagen, and Merus. According to TipRanks, Berens has an average return of 3.9% and a 46.50% success rate on recommended stocks.
In addition to SVB Securities, Seagen also received a Buy from JMP Securities’s Reni Benjamin in a report issued on November 2. However, on October 31, Stifel Nicolaus maintained a Hold rating on Seagen (NASDAQ: SGEN).
SGEN market cap is currently $24.68B and has a P/E ratio of -38.39.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Washington-based Seagen, Inc. is a biotechnology company, which is focused on developing and commercializing innovative, empowered monoclonal antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev.
Read More on SGEN: